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Abstract: Introduction  
There is increasing evidence of cancer patients presenting to emergency departments (ED). The study 
aim was to analyse the characteristics of adult cancer patients' presenting to one ED. Understanding 
cancer patient presentations could assist in the development of new models of care. 
 
Methods 
A 12 month retrospective audit was conducted of a random sample of cancer patients. Demographics 
and characteristic variables were analysed using descriptive, comparative and correlational statistics.  
 
Results 
The presentation rate for adult cancer patients was 1,110 (2.4%) with 290 sampled.  The common 
symptoms were fever (n=54:18.6%), abdominal pain (n=34:11.7%), and shortness of breath 
(n=32:11%). The majority of patients were allocated a Triage Category 2 (n=94:32.4%) or Triage 
Category 3 (n=131:45.2%). The majority of patients presented between 2 and 15 times. For patients 
administered antibiotics the average time was 119.8 minutes (SD +/- 85.5).  The average ED length of 
stay was mean 8.08 hours with 271 patients (93.4%) admitted to hospital. Of the 290 patients, 105 
(36.2%) had died within 12 months of ED presentation.  
 
Conclusion 
The study has shown that while cancer patients are only a small percentage of ED presentations the 
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A CROSS-SECTIONAL STUDY OF THE CLINICAL CHARACTERISTICS OF ONCOLOGY 1 
PATIENTS PRESENTING TO ONE SYDNEY TERTIARY REFERRAL EMERGENCY 2 
DEPARTMENT 3 
Introduction and Background 4 
Cancer is currently the leading cause of death worldwide and it is expected that 8 million more cancer cases 5 
will be diagnosed within the next two decades (WHO, 2014). It is estimated that 28,000 Australians will be 6 
diagnosed with cancer in 2014 (Australian Institute of Health and Welfare, 2014). The number of cases of 7 
cancer in Australia has doubled in size since 1991 and is the second most common cause of death. The risk 8 
of being diagnosed with cancer in Australia is 1 in 2 in males and 1 in 3 in females by the age of 85. The 9 
World Health Organisation Global Action Plan was launched in 2013 and aimed to reduce mortality from 10 
cancer by 25 per cent (WHO, 2014). 11 
Cancer is a chronic disease which contributes significantly to the burden of disease on society (Australian 12 
Institute of Health and Welfare, 2014). Emergency Departments (ED) are often the first point of entry for 13 
cancer patients requiring urgent care.  The advancements in cancer treatments and subsequent improved 14 
survival rates has led to an increase in ED presentations (Vandyk et al., 2012). 15 
From 2012 data Australian Hospital EDs had 6.5 million admissions per year demonstrating an increase of 16 
4.2 per cent between the years of 2007-2008 and 2011-2012 (Australian Institute of Health and Welfare, 17 
2012-2013). Many authors (Ahn et al., 2012; Royal College of Physicians, 2013; Ruegg, 2013) have 18 
suggested that cancer patients could seek appropriate treatments in alternative care models rather than 19 
accessing EDs. Therefore, the aim of the study was to explore the trends and characteristics of cancer patient 20 
presentations to one ED.  21 
Aim 22 
The primary aim of the study was to explore the prevalence and characteristics of adult cancer patients 23 
presenting to a tertiary referral hospital ED within the state of New South Wales, Australia.  24 
Methods 25 
This was a 12 month (1st January 2012 – 31st December 2012) retrospective cross-sectional study of cancer 26 
patients. This multi-method audit involved two phases to achieve the proposed research objectives.  Phase 27 
*Manuscript (without Author details)
Click here to view linked References
one included data that was extracted from First Net©, the ED Computer Software Program. The data 28 
retrieved included: patient demographic (age, medical record number, gender) and clinical information 29 
(arrival time to ED, triage code, doctor seen time, mode of arrival, diagnosis, nurse initiated protocols, 30 
admitting doctor, length of stay and discharge disposition). 31 
Phase two included a random sample that was selected from phase one. The sample size was identified using 32 
a 95% CI and 5% margin of error requiring a minimal sample of 286. A medical record audit of adult cancer 33 
patients from the ED data set was conducted. Medical records were manually reviewed and the data retrieved 34 
included: clinical information (nurse initiated protocols, time to antibiotics, pain score, time to analgesia, 35 
date of last chemotherapy and radiotherapy treatment, personal protective equipment, central venous access 36 
devices, and discharge disposition).  37 
Data was stored electronically in a security password protected Excel database accessible only by the chief 38 
investigators.  Descriptive, comparative and correlational statistical analysis was performed with the aid of 39 
the IBM SPSS program (IBM SPSS v.21, Chicago IL USA).   40 
Ethical Approval 41 
Ethical approval was obtained from the Northern Sydney Local Health District Human Research Ethics 42 
Committee. The ethical conduct of research was maintained during and after the research. All data sources 43 
were stored in password protected file and stored in a locked cupboard only accessible by the chief 44 
investigators. All patients were immediately de-identified and re-coded to ensure confidentiality, beneficence 45 
and privacy.  46 
Results 47 
For the 12 month study the ED presentation rate was 62,919 including adults (n=47,164: 75%) and 48 
paediatrics (n=15,755: 25%). There were 24,048 females (51%) and 23,116 males (49%). The cancer 49 
presentation rate was 1,110 (2.4%).  The medical record audit comprised 290 patients (Table 1). The 50 
majority of patients were oncology (255:87.9%) compared with haematology (n=35:12%).   The majority of 51 
patients (n=183:63%) arrived by private transport and one third of patients (n=99: 34.1%) arrived by 52 
ambulance.  53 
Of the 290 patients the average age was 65.3 years and gender was evenly split across the groups (female 54 
n=146:50.3%). The three most common symptoms on presentation were fever (n=54:18.6%), abdominal pain 55 
(n=34:11.7%) and shortness of breath (n=32:11.0%) (Table 2). Patients were also found to present due to 56 
abnormal test findings (n=29:10%). The majority of patients (n=231: 79.7%) presented between Monday and 57 
Friday and between business hours of 0800-1700 (n=173:59.7%). The majority were allocated Triage 58 
Category 2 (n=94:32.4%) or Triage Category 3 (131:45.2%). There was no statistical difference in triage 59 
code allocation and time of day (p=.282) or weekday presentation and gender (p=.931) comparing cancer 60 
patients with ED presentations. 61 
The average time for nurse initiated interventions was 25 minutes (SD +/-18.5). The most common nurse 62 
initiated intervention was pathology and cannulation (n=117:40.3%) followed by the administration of 63 
analgesics (n=54:18.6%) and or antiemetic (n=8:2.8%).  64 
For those arriving in pain 52 (18%) had a pain score greater 50mm (Table 1). The average time to nurse 65 
initiated analgesia was 30.7minutes (SD +/-40.9). There was no statistical difference in time to analgesia for 66 
gender. There was no difference between the time to analgesia when comparing haematology and oncology 67 
patients (p=0.292: CI 95%).  There was a statistical difference when comparing triage code and time to 68 
analgesia (X
2
 274.224: p=.000). There was a weak correlation between triage code and time to analgesia 69 
(Spearman’s rho -.047 p=.638). There was no statistical difference when comparing day (p=.094) or time 70 
(p=.078) of presentation for time to analgesia.  71 
For patients receiving antibiotics the average time was 119.8 minutes (SD +/- 85.5). There was statistical 72 
difference when comparing triage code and time to antibiotics (X
2 
274.224: p=.000). The time to antibiotics 73 
for oncology patients (125.6min: SD +/- 87.36) was longer than for haematology patients (mean 88.3min: 74 
SD +/-69.21). There was no difference between time to antibiotics when comparing febrile neutropenia and 75 
the other diagnostic groups (p=.908: CI 95%). There was no statistical difference when comparing day 76 
(p=.044) or time (p=.68) of presentation for time to antibiotic. 77 
There were 96 patients (33.1%) who received chemotherapy within one week of presentation and 44 (15.2%) 78 
who received chemotherapy within one day.  Of the 96 patients the majority (n=68; 71.0%) were allocated 79 
Triage Category 2. Of the 44 patients, 34 (77.3%) presented during the work week with 10 (22.7%) 80 
presenting over the weekend (p=.001). Of the 44 patients fever (n=12: 27%), dyspnoea (8:18.2%) abdominal 81 
pain and vomiting (n=8; 18.2%) were the most common symptom presentation. There was no statistical 82 
difference noted between groups (X
2
 p=.350)  83 
Of the 96 patients that had received chemotherapy within one week of ED presentation there was 84 
documented evidence of cytotoxic personal protective precautions being used for 33 (34.3%) patients. 85 
Within 12 months of ED presentation 41 (14%) patients had received radiotherapy, and of that group 15 86 
(36.5%) had received radiotherapy within four weeks.  87 
There were 27 (9.3%) patients that had a central venous access implanted device (CVAD) documented in the 88 
medical record. Of the 27 patients with an implanted CVAD, 15 (55.5%) patients had their device accessed 89 
in the ED.  Six patients (22.2%) had a cannula inserted despite the presence of a CVAD.  90 
Over 12 months the majority of patients (n=162:56%) presented on average 3.4 times. Haematology patients 91 
(mean 3.7) presented slightly more frequently than the oncology group (mean 3.3). The length of stay for 92 
cancer patients was greater (mean 8.08 hours SD +/- 20 minutes) than the ED length of stay (mean 5:06 93 
hours: SD +/- 15minutes) for total presentations.  94 
The majority of patients (n=271; 93%) were admitted to hospital. Nine (3.10%) were discharged with three 95 
(1.03%) transferred to another hospital.  Five (1.72%) patients were transferred to a critical care area with 96 
two (0.69%) dying in the ED. The average hospital length of stay for the cancer group was 7.1days. 97 
Of the 290 patients, 70 patients (24.1%) presented once to the ED over the study period. There were 58 98 
(20%) patients that presented twice with the majority of patients (n=162; 56%) presenting more than three 99 
times. There were 201 patients that presented between two and seven times and 19 that presented between 100 
eight and 15 times.  101 
Of the 290 cancer patients, 105 (36.2%) died within 12 months of ED presentation. There was no correlation 102 
between presentation day and death rate (p=.641) 103 
Discussion 104 
This study has demonstrated that cancer patients visiting the ED had a high acuity and that the majority of 105 
patients were admitted (93%). Of the study sample 36% of patients had died within 12 months of ED 106 
presentation. This finding is supported by a population study that analysed patterns of cancer patients 107 
presenting to New South Wales EDs, which found 32.21% died within 12 months (Bureau of Health 108 
Information, 2014). This study suggests that an ED presentation for cancer patients could be a high predictor 109 
of mortality rate. 110 
Patients that are undergoing chemotherapy are at a high risk of developing febrile neutropenia (Naurois et 111 
al., 2010; Penack et al., 2010). Febrile neutropenia (FN) is one of the serious complications of cancer therapy 112 
and is a major cause of mortality. The diagnosis of febrile neutropenia was made in 10.6% of patients in this 113 
study and all required antibiotics. The study highlighted that cancer patients had an average time to antibiotic 114 
of 119.8 minutes. International guidelines state that the administration of intravenous antimicrobials within 115 
the first hour should be the goal of therapy (Dellinger et al., 2013). EDs need to develop fast tracking 116 
protocols of antimicrobial treatments for febrile neutropenic patients to ensure a rapid response when a 117 
patient is suspected of this diagnosis (Naurois et al., 2010).  While requiring antibiotics is an appropriate 118 
reason for presenting to Australian EDs the time delay experienced by cancer patients in our study warrants 119 
service reform and further research.  120 
Our findings identified that cancer patient’s visit the ED frequently within a 12 month period. The vast 121 
majority presented between two and 15 times. These findings suggest that the current model of care may not 122 
be providing an appropriate support to meet the needs of cancer patients. Globally, different models of care 123 
have been introduced to reduce ED presentations, overcrowding and admission rates for cancer patients 124 
(Royal College of Physicians, 2013).  125 
A study by Ahn (2012) in Korea explored the impact of opening a cancer emergency room in the ED. This 126 
study demonstrated a significant reduction in ED admission rates and hospital savings of 10.89%. 127 
Furthermore, in the USA, Ruegg (2013) argues for Nurse Practitioner led oncology urgent care centres to 128 
provide specialty cancer services to alleviate ED overcrowding (Ruegg, 2013). Again in the UK an acute 129 
oncology medical service was established to provide advice, timely assessment reviews, symptom 130 
management and alternative admission processes to reduce ED overcrowding, presentations and admissions 131 
(Royal College of Physicians, 2013). These models need to be further explored to determine the potential 132 
utility and impact for the Australian context. 133 
A large proportion of cancer patients receive chemotherapy at some stage during their illness (McKenzie et 134 
al., 2011). Chemotherapy is well documented for causing side effects that can be distressing for patients 135 
(Aprile et al., 2013). In our study 44 (n=290) patients presented within 24 hours of receiving chemotherapy. 136 
Today, over 90% of cancer patients receive chemotherapy treatment in the ambulatory care setting. For many 137 
people with cancer managing the side effects of treatment can be challenging in the home setting. Better 138 
integrated ambulatory oncology services with home management plans and community support could 139 
potentially reduce ED presentations for symptom relief of cancer treatment (McKenzie et al., 2011). 140 
International research identified strategies that have been implemented to improve supportive care of people 141 
with cancer.  In the UK a 24 hour cancer telephone support service has been established to improve symptom 142 
related cancer management for those patients in the community (Royal College of Physicians, 2013). 143 
Similarly, in the USA cancer patients have access to comprehensive educational resources which are also 144 
linked to social media forums (National Comprehensive Cancer Network, 2015). These strategies have been 145 
shown to better support healthcare decision-making and selection of appropriate services to meet individual 146 
patient needs. Future Australian research needs to explore the role of help lines, social media and community 147 
support for cancer patients.  148 
Fever, abdominal pain and shortness of breath accounted for the majority of cancer presentations to the ED 149 
in this study. It was found that cancer patients presented for symptoms associated with treatment and cancer 150 
type. Globally these findings are consistent across EDs (Ahn et al., 2012; Bureau of Health Information, 151 
2014; Leak et al., 2013; Sadik et al., 2014; Vandyk et al., 2012).  152 
Internationally and nationally cancer patients often present to the ED in the terminal phase of illness (Ahn et 153 
al., 2012; Bureau of Health Information, 2014; Leak et al., 2013). Our study identified that 36% of patients 154 
died within 12 months of ED presentation. A New South Wales report identified that 75% of cancer patients 155 
attended an ED within 180 days of dying (Bureau of Health Information, 2014).  Further research into end of 156 
life care and ED utilisation is needed to explore new palliative care models to assist patients in the terminal 157 
phase of illness. 158 
Conclusion 159 
The study has shown that while cancer patients are only a small percentage of total ED presentations the vast 160 
majority are allocated high triage codes, have high admission rates and a high mortality rate. Timely and 161 
appropriate emergency care needs to target vulnerable groups such as febrile neutropenia to optimise 162 
outcomes and reduce morbidity and mortality rates.  163 
Appropriate community based symptom management care models for cancer patients needs to be established 164 
to reduce ED presentation rates for this group. New ED models of care need to be investigated to determine 165 
how we can better support people with cancer during all stages of illness.  166 
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Table 1: Characteristics of cancer patient presentations to the ED (n=290) 
       Group     N   Oncology   Haematology   
Gender 
Female    146 (50.4%)  128 (50.20%)  18 (51.43%) 
Male     144 (49.6%)  127 (49.80%)  17 (48.57%) 
Age 
Mean Years (SD)  65.3 (15.3)  65.9 (14.8)   61.3 (16.7) 
Triage code  
1    6 (2.07%)   6 (2.07%)   
2     94 (32.41%)  82 (28.28%)  12 (4.14%) 
3    131 (50.59%)  115 (39.66%)  16 (5.52%) 
4    54 (18.62%)  47 (16.21%)  7 (2.417%) 
5    5 (1.72%)   5 (1.72%) 
Top diagnostic groups  
Cancer non defined 104 (35.86%)  104 (35.86%) 
Febrile neutropenia  31 (10.6%)   29 (10.0%)  2 (0.69%) 
Pancreatic cancer   20 (6.9%)   20 (6.9%)   
Lung cancer   17 (5.86%)  17 (5.86%) 
Bowel cancer   12(4.14%)  12(4.14%) 
Leukemia    10 (3.45%)      10 (3.45%) 
Hodgkin’s lymphoma  10 (3.45%)      10 (3.45%)  
Arrival by day  
Weekday   231 (79.7%)        p=.001  X2 
Weekend   59 (20.3%) 
Monday   51 
Tuesday   40 
Wednesday   49 
Thursday  47 
Friday   44 
Saturday  23 
Sunday   36 
Time of day  
8.00-17.00    173   (59.7%) 
Table
1701.7.59   117 (40.3%) 
 
  
Time to antibiotics  
TTABs minutes mean (SD)  119.8 (85.5min) 125.6 (87.36)  88.3 (69.21)  
Pain Scores 
Presenting with pain  155 (74.1%) 
<50mm    103 (34.5%)   
>50mm    52 (18%) 
Time to Analgesia  
TTA minutes mean (SD) 47.5 (42.3)  29.9 (41.1)  36.7 (39.6) 
Disposition  
Admitted to hospital  271 (93%)  124 (68%)  34 (97.1%) 
Transfer to critical care area 5 (1.72%)  1(0.5%) 
Died in ED   2 (0.69%)  2 (0.78%) 
Transfer to another hospital 3 (1.03%)  2 (0.78%)  1(2.86%)  
Discharged from ED  9 (3.5%)  9 (3.53%)   
Table 2: Presenting symptoms for cancer patients in ED (n=290) 
       Group     N (%)    
Fever    54 (18.62%)     
Abdominal pain   34 (11.72%)   
Shortness of breath  32 (11.03%) 
Abnormal blood tests  29 (10.0%) 
Other    26 (8.97%) 
Vomiting    16 (5.52%) 
Pain    14 (4.83%) 
Falls    13 (4.48%) 
Dyspnea    8 (2.76%) 
Lethargy    8 (2.76%) 
Nausea      7 (2.41%)  
Diarrhea    6 (2.07%)  
Mobility    6 (2.07%) 
Headache   5 (1.72%)  
Dehydration   4 (1.38%) 
Myelosuppresion   3 (1.03%) 
Constipation   3 (1.03%)      
Dizziness    3 (1.03%) 
Allergy    2 (0.69%) 
Fungal infection    2 (0.69%) 
    






 Cancer patients visiting the Emergency Department had a high acuity with the majority admitted to 
hospital for an average length of stay of seven days  
 Timely emergency care needs to target vulnerable groups to optimise outcomes and reduce 
morbidity and mortality rates 
 Appropriate community care models need to be established to reduce ED presentation rates and to 
better support people with cancer during all stages of illness  
 A cancer patient emergency presentation could be a high predictor of mortality  
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